Sookjin Lee

Chief Business Officer (CBO) | Ph.D.

A business expert leading innovation in precision medicine and genomics for 20 years. Accelerating the commercialization of innovative technologies with academic expertise and market insight.

Is Metabolomic Testing Enough for IEMs? Why Genomics Matters in the NICU2026. 10. 26
Still Undiagnosed After Whole Genome Sequencing? Here is How to Solve It.2026. 10. 19
Unlocking the “Unmappable” D4Z4 Repeat: How 3billion Mastered FSHD Diagnosis with Long-Read Sequencing2026. 10. 07
Mitochondrial Disease Doesn’t Arrive Looking Typical2026. 09. 15
[On the Road to Meet] “Designing the System Together as True Partners” — Changdeok Ji, Rare Disease Business Architect (Part 2)2026. 08. 26
[On the Road to Meet] “Expanding the Market to Speed Up Diagnosis” — Changdeok Ji, Rare Disease Business Architect (Part 1)2026. 08. 26